Today: 21 November 2025
Subscribe
Browse Category

Investment Analysis News 9 October 2025 - 11 October 2025

TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC Stock Soars on AI Boom TSMC (Taiwan Semiconductor Manufacturing Co.) is riding a wave of investor enthusiasm as of October 2025. Its Taipei-listed shares hit record highs this month – reaching NT$1,370 on Oct 2 (about $43 USD per share) ts2.tech – and the U.S. ADR (NYSE: TSM) likewise surged to all-time highs, briefly trading above $300. In fact, TSMC’s U.S. stock spiked to an intraday $307 on Oct 7 amid frenzied buying ts2.tech. Even after a bit of profit-taking, TSMC hovers around the mid-$290s per share as of Oct 11, reflecting a dramatic upswing from roughly ~$200 at
11 October 2025
 ·  ·  ·  ·  · 
Up 150% YTD: Navitas Semiconductor (NVTS) Rides the GaN Power Wave into AI’s Future

Up 150% YTD: Navitas Semiconductor (NVTS) Rides the GaN Power Wave into AI’s Future

Company Background and Business Model Navitas Semiconductor is a fabless semiconductor company founded in 2014 that specializes in next-generation power electronics. It pioneered the integration of gallium nitride (GaN) transistors with drive, control, sensing, and protection circuits into single “GaNFast” power ICs navitassemi.com. These GaN power chips switch much faster than traditional silicon, enabling smaller, more efficient chargers and power converters. Navitas’s technology can increase energy efficiency by up to 40% and switch speeds 100× faster than legacy silicon solutions navitassemi.com, allowing power systems to be significantly lighter and more compact. The company initially gained traction in consumer electronics – its GaN ICs have been used in ultra-fast smartphone
10 October 2025
 ·  ·  ·  ·  · 
MP Materials Stock Skyrockets on Pentagon Deal and Apple Alliance – Rare Earth Boom or Hype?

Rare Earth Boom: MP Materials Stock Skyrockets on Pentagon Deal, China Curbs – Hype or Game-Changer?

China’s Rare Earth Stranglehold Sparks U.S. Action Rare earth elements – a group of 17 metals like neodymium, praseodymium, dysprosium, and terbium – may not be household names, but they are the lifeblood of modern tech and defense industries. They power the magnets in electric vehicle motors and wind turbines, enable the miniaturization of smartphones and precision-guided missiles, and are critical for fighter jet engines and satellites. For years, the United States has been almost entirely dependent on imports of these resources, especially from China ts2.tech. In fact, China currently accounts for roughly 70% of the world’s rare earth ore production and over 90% of
10 October 2025
 ·  ·  ·  ·  ·  · 
Massive Moves: Record Deals, FDA Wins & Crypto Mania Propel Top Stock Gainers (Sep 29, 2025)

Record Rally Stalls as Fed Cut Bets Soar and Earnings Loom

Rally Pauses After New Highs as Market Seeks Direction After a streak of record-setting gains, Wall Street’s rally took a breather heading into the weekend. On Wednesday the S&P 500 and Nasdaq notched all-time closing highs, but Thursday saw a mild pullback across major indices nasdaq.com. The S&P 500 dipped about 0.3% Thursday (to ~6,735), the Dow fell 0.5%, and the Nasdaq Composite slipped 0.1% econotimes.com, pausing a record-breaking tech-driven surge. High-flying semiconductor and AI stocks led the dip – for instance, Dell Technologies tumbled -5% and Micron -2% amid profit-taking nicoop.com. Even with that consolidation, the uptrend remains intact: the S&P and Nasdaq are
10 October 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Blockbuster Q3 Earnings – Sales Beat and Outlook Raised Levi Strauss & Co. delivered strong third-quarter 2025 results, topping estimates and defying retail sector headwinds. Revenue for Q3 (June–August 2025) hit $1.54 billion, up 7% year-on-year and slightly above analyst expectations of ~$1.50 billion reuters.com tipranks.com. Adjusted earnings were $0.34 per share, a penny higher than a year ago and beating the $0.31 consensus estimate tipranks.com. The company achieved broad-based growth across channels, regions, and product categories. Direct-to-consumer (DTC) sales – through Levi’s own stores and website – surged +11%(organically +9%), now making up 46% of total revenue benzinga.com benzinga.com. Notably, e-commerce sales jumped 16% as Levi’s leaned into online and full-price selling reuters.com. This
10 October 2025
 ·  ·  ·  ·  · 
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco Stock Soars Amid Retail Gloom – What’s Driving the Rally and Will It Last?

Stock Price & Recent Performance Costco’s stock has been on a long-term upward climb, and 2025 is no exception – though it hasn’t been a smooth ride. After a strong rally in the first half of the year, Costco (COST) shares reached an intraday record high around $1,078earlier in 2025 ts2.tech. Enthusiasm was fueled by robust sales growth and a broader market rally. However, by late summer the stock had pulled back into the mid-$900s amid some profit-taking and market volatility ts2.tech. As of October 9, 2025, COST trades in the $914–$928 range ts2.tech – essentially back to where it started the year
9 October 2025
 ·  ·  ·  ·  · 
CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

Company Background & Business Model Cipher Mining is a pure-play Bitcoin miner that specializes in large-scale, energy-efficient data-center mining ts2.tech. It locates facilities “behind the meter” at low-cost renewable power sites in West Texas ts2.tech. Its flagship “Black Pearl” complex (Odessa, TX) is a 150 MW facility serving both Bitcoin mining and high-performance computing (HPC) ts2.tech. As of mid-2025, Cipher had deployed ~16.8 EH/s of mining capacity (with next-gen ASIC miners) ts2.tech and plans to reach ~23.5 EH/s by Q3’25 ts2.tech. To fund growth, it has a large 2.6 GW pipeline of additional power projects ts2.tech. In Q2’25 Cipher produced ~150 BTC and achieved $44 M
9 October 2025
 ·  ·  ·  ·  · 
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing stockanalysis.com. Turn’s mission is to “turn the tides” in medicine by developing technologies that heal, not just manage, challenging traditional treatments benzinga.com. CEO Bradley Burnam (the founder) leads a lean operation “built on a shoestring, with an absolute disdain for waste,” as he emphasized during the Nasdaq bell-ringing ceremony benzinga.com. Burnam and his team bring a “patient-first” approach and a frugal business model to drug development, aiming
9 October 2025
 ·  ·  ·  ·  · 
Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Background and Pipeline Intellia was an early pioneer of in-vivo CRISPR therapy. Based in Cambridge, MA, it was among the first to administer CRISPR-Cas9 therapies directly into patients ts2.tech. In 2021 Intellia reported the first clinical proof that in-body CRISPR editing could work – a single injection dramatically lowered the disease protein (transthyretin) in ATTR amyloidosis patients ts2.tech. Today, the company’s focus is on curative gene edits in severe diseases. Its lead programs are NTLA-2001 (nexiguran ziclumeran) for transthyretin amyloidosis (ATTR) and NTLA-2002 (lonvoguran ziclumeran) for hereditary angioedema (HAE) ts2.tech ts2.tech. Both use CRISPR delivered via lipid nanoparticles to
9 October 2025
 ·  ·  ·  ·  · 
PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

Key Data & Metrics (as of October 9, 2025) Metric Value Stock Price (Oct 8, 2025) $138.84 (close) marketbeat.comDown ~6% in past month; ~–6% YTD finviz.com indexbox.io 52-Week Range Low $127.60 – High $177.48 markets.businessinsider.com Market Capitalization ~$193 Billion markets.businessinsider.com Forward P/E (2025E) ~17.5× (near industry avg ~17.5×) finviz.com Trailing P/E (TTM) ~21.8× markets.businessinsider.com PEG Ratio (Forward) ~3.5 (industry ~2.3) finviz.com Annual Dividend $5.69 per share (yield ~4.0%) macrotrends.net Dividend Growth 53 years consecutive increases (5% hike in 2025) pepsico.com Q3 2025 Revenue $23.94 B (+2.6% YoY) investing.com Q3 2025 Adjusted EPS $2.29 (beat est. $2.26; –1.7% YoY) investing.com finviz.com 2025 Full-Year
9 October 2025
 ·  ·  ·  ·  · 
Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s Strong Quarter Signals a Turnaround Tilray Brands kicked off its fiscal 2026 with better-than-expected results, signaling that aggressive cost-cutting and diversification efforts are bearing fruit. The company’s Q1 FY2026 revenue hit $209.5 million, a 5% increase over last year’s quarter stocktitan.net. More impressively, Tilray managed to swing to a net profit of $1.5 million (or $0.00 per share) – a stark improvement from the -$34.7 million loss in the prior-year period stocktitan.net stocktitan.net. This marks one of Tilray’s first profitable quarters since its 2018 IPO, a milestone achieved through tighter operational discipline. Adjusted EBITDA came in at $10.2 million
9 October 2025
 ·  ·  ·  ·  · 
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – Inside the Price Surge, Latest News & 2025 Outlook

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – Inside the Price Surge, Latest News & 2025 Outlook

Stock Price Surge: From IPO to Record Highs Tempus AI’s stock has been on a remarkable tear since its mid-2024 IPO. The Chicago-based healthtech firm – founded in 2015 by Eric Lefkofsky (of Groupon fame) – went public in June 2024 at around $21 per share, and the price has since quadrupled ts2.tech. After a steady climb through 2024, momentum accelerated in 2025 as the company delivered strong results and AI breakthroughs. By early September 2025, TEM had more than doubled its IPO price, reaching the high-$80s to $90 range ts2.tech. A series of catalysts (detailed below) then propelled the
9 October 2025
 ·  ·  ·  · 
1 … 26 27 28 29 30 31
Go toTop